Forschung
Lehre
Lösungen
Anmelden
DE
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Oral and Maxillofacial Diseases,
Clinicum,
Faculty of Medicine,
Department of Oral and Maxillofacial Diseases, Clinicum, Faculty of Medicine
Tuula Salo has not added Biography.
If you are Tuula Salo and would like to personalize this page please email our Author Liaison for assistance.
Improved outcomes with oral tongue squamous cell carcinoma in Finland.
Head & neck 07, 2017 | Pubmed ID: 28481417
Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.
BMC cancer 05, 2017 | Pubmed ID: 28526008
Cross-reactive saliva IgA antibodies to oxidized LDL and periodontal pathogens in humans.
Journal of clinical periodontology Jul, 2017 | Pubmed ID: 28548243
Organotypic three-dimensional assays based on human leiomyoma-derived matrices.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences Jan, 2018 | Pubmed ID: 29158312
Human Tumor Tissue-Based 3D In Vitro Invasion Assays.
Methods in molecular biology (Clifton, N.J.) , 2018 | Pubmed ID: 29318556
Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer.
Nature communications 09, 2018 | Pubmed ID: 30185791
The prognostic value of immune checkpoints in oral squamous cell carcinoma.
Oral diseases Oct, 2018 | Pubmed ID: 30315712
Potential role of nuclear magnetic resonance spectroscopy to identify salivary metabolite alterations in patients with head and neck cancer.
Oncology letters Nov, 2018 | Pubmed ID: 30344764
Proliferative verrucous leukoplakia and its tumor markers: Systematic review and meta-analysis.
Head & neck May, 2019 | Pubmed ID: 30536498
Matrix metalloproteinase 9 inhibits the motility of highly aggressive HSC-3 oral squamous cell carcinoma cells.
Experimental cell research Mar, 2019 | Pubmed ID: 30710501
University of Helsinki
University of Oulu
Oulu University Horspital
Helsinki University Hospital
University of oulu
Erika Naakka1,
Katja Tuomainen1,
Henrik Wistrand*,1,
Miila Palkama*,1,
Ilida Suleymanova1,
Ahmed Al-Samadi1,
Tuula Salo1,2,3,4
1Department of Oral and Maxillofacial Diseases, Clinicum, Faculty of Medicine, University of Helsinki,
2Cancer and Translational Medicine Research Unit, University of Oulu,
3Medical Research Center, Oulu University Horspital,
4, Helsinki University Hospital
Datenschutz
Nutzungsbedingungen
Richtlinien
Kontakt
BIBLIOTHEKS-EMPFEHLUNG
JoVE-Newsletter
JoVE Journal
Methodensammlungen
JoVE Encyclopedia of Experiments
Archiv
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Ressourcen für Lehrende
Autoren
Bibliothekare
Zugang
ÜBER JoVE
Copyright © 2024 MyJoVE Corporation. Alle Rechte vorbehalten